Risks of dementia and stroke in patients with hypertension using telmisartan or other renin‑angiotensin system inhibitors

Documenti analoghi

• Blood markers of the renin‐angiotensin system and cognitive impairment: The Look AHEAD Study
  di: Sevil Yasar, et al.
  Pubblicazione: (2025)
• Association between ischemic stroke, hemorrhagic stroke, dementia, and rs201118034 among general Taiwanese population
  di: Yi‐Chia Liaw, et al.
  Pubblicazione: (2025)
• Repurposing renin‐angiotensin system‐targeting medications for treatment of cerebral amyloid angiopathy and associated cognitive‐behavioral deficits in Tg‐SwDI mice
  di: Ariana Hernandez, et al.
  Pubblicazione: (2024)
• Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment
  di: Ahmed Negida, et al.
  Pubblicazione: (2024)
• Sodium‐glucose cotransporter‐2 inhibitors use and risk of dementia in different ethnoracial groups with type 2 diabetes
  di: Shih‐Chi Yang, et al.
  Pubblicazione: (2024)